Bridging 'Innovation & Investment'
Oyster directly supports emerging healthcare technology companies with raising their first significant investment rounds, £/€/$5m-50m+. Such early-to-mid stage technology-focused companies frequently seek advisory and execution support when raising capital. Oyster provides full support on a modular basis from 1) raising client investment collateral to investor-ready standards, e.g. business plans and slide decks, 2) identifying, qualifying, approaching and engaging clients with investors, and 3) supporting investment transaction development through to closure.

Products and services

Financial

Raising capital, Mergers and acquisitions

Industry

Biotechnology and pharmaceuticals, Healthcare and medical, Life sciences

Regional

North East, North West, Northern Ireland, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West, Scotland, Wales

International

Australia, Austria, Belgium, Brazil, China, Denmark, Finland, France, Germany, Ireland, Italy, Japan, Monaco, Netherlands, New Zealand, Norway, Poland, Singapore, South Africa, Spain, Switzerland, United Kingdom, United States